Image

Adaptation of the NEAR Cognitive Remediation Method to Child and Adult Autism by Including Social Scenarios and Skills

Recruiting
13 - 40 years of age
Both
Phase N/A

Powered by AI

Overview

The investigators currently provide the NEAR method (neuropsychological educational approach to cognitive remediation) for people with neurocognitive difficulties, without distinguishing between ASD and schizophrenia.

However, the NEAR method does not address social cognition in the stimulated functions. The aim of this study is to add social scenarios to this neurocognitive method in order to improve not only neurocognitive functions, but also social cognition. Thus, NEAR would be in this adapted form a method that could be completely adapted to autism spectrum disorders in preadolescents and adults.

The study will include participants aged 13-40 years, with a diagnosis of ASD.

The NEAR TSA method will include 32 sessions:

  • one session (90-120 min, with one or two breaks) per week for 32 weeks (8 months), for minor participants.
  • two sessions (90 minutes each, with no breaks) per week for 16 weeks (4 months), for adult participants.

The method includes 30 minutes of computerized exercises, 15 minutes of discussion on the exercises performed and the strategies applied, and the rest of the time for "bridging groups".

Three evaluation are proposed:

  • an initial clinical and functional evaluation (T1), before the beginning of the program,
  • a second clinical, functional and neuropsychological evaluation (T2), within one month since the end of the program
  • a third clinical, functional and neuropsychologica evaluationl (T3), three months after the end of the program.

Description

Inclusion age:two samples: 13 to 15 years old and 16 to 40 years old the clinical evaluation (T1,T2, T3) includes: global functional assessment; questionnaires for children and adults including the self esteem questionnaire, quality of life (who_QOL Bref), social responsiveness scale, conversational skills (CCC-2 for children; Pomini Scale for adults), intrinsic motivational scale (Medalia), Satisfaction scale (CSQ8).

The Neuropsychological evaluation (T1, T2, T3) includes: WISC5 (children), WAIS 4 (adults), stroop test, D2-R, Child memory scale or Wechsler Memory scale for adults, Brief, color trail test, verbal fluency.

Near TSA is a group cognitive remediation method, including one weekly session for children or 2 weekly sessions for adults with 30 mn of neuropsychological exercices, 15 mn of discussion about exercices and strategies, and 30 mn of bridging groups including social scritps.

Eligibility

Inclusion Criteria:

  • Patients with a diagnosis Autism Spectrum Disorder (ASD) - (DSM5)
  • Attending one of the outpatient units participating in the research
  • Diagnosis confirmed by the ADI (Autism Diagnostic Interview) with at least one parent present; or by the ADOS (Autism Diagnosis Observation Schedule)
  • Score of at least 7 on the WISC5 (children) or WAIS4 (adults) comprehension subtest
  • Patient whose neuropsychological evaluation shows neurocognitive impairment as assessed by the neuropsychologist
  • Level of comprehension and communication allowing to understand the instructions of the exercises presented on the screen.
  • For children, persons who can attend a non-specialized school
  • If the patient is being treated with a psychotropic drug: stability of treatment for more than one month.

Exclusion Criteria:

  • Previously known diagnosis of intellectual disability
  • Misunderstanding of questions or instructions given during the diagnostic interview
  • Proven neurological pathology
  • Persons treated with electroconvulsive therapy within the last 6 months
  • Uncorrected sensory perception disorder
  • Patient participating in another research study with an exclusion period still in progress at inclusion
  • Treatment with daytime anxiolytics, and treatment with anticholinergic correctors
  • Pregnant or breastfeeding woman
  • Participants who have had cognitive remediation in the last two years

Specific exclusion criteria for the "adult" group:

  • heterogeneous levels of development highlighted in the diagnostic workup including an examination of cognitive functions

Specific exclusion criteria for the "children" group:

  • out-of-school children

Study details

Autism Spectrum Disorder

NCT05786898

Centre Hospitalier St Anne

26 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.